[Federal Register Volume 72, Number 128 (Thursday, July 5, 2007)]
[Notices]
[Page 36729]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-12948]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated April 18, 2006, and published in the Federal 
Register on April 25, 2006, (71 FR 23948), Cody Laboratories, Inc., 601 
Yellowstone Avenue, Cody, Wyoming 82414, made application by letter to 
the Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the basic classes of controlled substances listed in 
schedule II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Methadone (9250)...........................  II
Alfentanil (9737)..........................  II
------------------------------------------------------------------------

    The company plans to manufacture in bulk, for distribution to its 
customers.
    An objection and a request for a hearing were received by the DEA. 
In accordance with 21 1301.33 bulk manufacturers applying for or 
registered in the same basic class of narcotic or non-narcotic 
controlled substances may submit to the DEA any comments on or 
objections to the issuance of a proposed application. This regulation 
does not provide bulk manufacturers the right to request a hearing on 
the proposed application. No hearing was scheduled to be heard on this 
matter. DEA has reviewed the objection made against this pending 
application and has determined that the registration of Cody 
Laboratories, Inc. to manufacture the listed basic class of controlled 
substance is consistent with the public interest at this time. DEA has 
investigated Cody Laboratories, Inc. to ensure that the company's 
registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the 
above named company is granted registration as a bulk manufacturer of 
the basic class of controlled substance listed.

    Dated: June 26, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E7-12948 Filed 7-3-07; 8:45 am]
BILLING CODE 4410-09-P